RNAi Modulation of Placental sFLT1 for the Treatment of Preeclampsia.

Preeclampsia (PE) is a placentally-induced hypertensive disorder of pregnancy that is associated with significant morbidity and mortality to mothers and fetuses. Clinical manifestations of preterm PE result from excess circulating soluble vascular endothelial growth factor receptor FLT1 (sFLT1 or sV...

Fuld beskrivelse

Na minha lista:

Bibliografiske detaljer
Udgivet i:	Nat Biotechnol
Main Authors:	Turanov, Anton A., Lo, Agnes, Hassler, Matthew R., Makris, Angela, Ashar-Patel, Ami, Alterman, Julia F., Coles, Andrew H., Haraszti, Reka A., Roux, Loic, Godinho, Bruno MDC, Echeverria, Dimas, Pears, Suzanne, Iliopoulos, Jim, Shanmugalingam, Renuka, Ogle, Robert, Zsengeller, Zsuzsanna K., Hennessy, Annemarie, Karumanchi, S. Ananth, Moore, Melissa J., Khvorova, Anastasia
Format:	Artigo
Sprog:	Inglês
Udgivet:	2018
Fag:	Article
Online adgang:	https://ncbi.nlm.nih.gov/pmc/articles/PMC6526074/ https://ncbi.nlm.nih.gov/pubmed/30451990 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/nbt.4297
Tags:	Tilføj Tag Ingen Tags, Vær først til at tagge denne postø!

RNAi Modulation of Placental sFLT1 for the Treatment of Preeclampsia.

Lignende værker